Gentherm, Attune Medical announce non-exclusive distribution agreement

Attune Medical and Gentherm have entered a non-exclusive distribution agreement for healthcare providers in need of proactive esophageal cooling technology. Adopters of Attune’s ensoETM thermal regulating device will be provided the opportunity to use a bundled disposable purchase option to acquire Gentherm’s Blanketrol III directly from Attune. Attune will also offer customers a 90-day evaluation program for the Blanketrol III. Attune Medical’s ensoETM is a single use thermal regulating device that is placed in the esophagus and connected to an external heat exchange unit such as the Blanketrol III, creating a closed-loop system for heat transfer to increase or decrease patient temperature. Its placement in the esophagus, with proximity to blood flow from the heart and great vessels, allows highly efficient heat transfer. Unlike surface warming devices, ensoETM’s internal placement doesn’t impede patient access during surgery and allows gastric decompression and administration of fluids and medications. The Blanketrol III is used to lower or to raise a patient’s temperature and/or maintain a desired temperature through conductive heat transfer.